{
  "segment": [
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 25402,
      "profit": 4823,
      "assets": 22092
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 35746,
      "profit": 2714,
      "assets": 54136
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 105232,
      "profit": 10191,
      "assets": 78380
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 26775,
      "profit": 5687,
      "assets": 21173
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 35971,
      "profit": 2943,
      "assets": 56305
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 106319,
      "profit": 11989,
      "assets": 76320
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 26494,
      "profit": 6208,
      "assets": 21394
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 35444,
      "profit": 2386,
      "assets": 55791
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 110750,
      "profit": 16909,
      "assets": 78599
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 27424,
      "profit": 7216,
      "assets": 22558
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 30301,
      "profit": 1057,
      "assets": 55264
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 120636,
      "profit": 18785,
      "assets": 88114
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 27814,
      "profit": 7388,
      "assets": 22999
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 32202,
      "profit": 1967,
      "assets": 58809
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 127512,
      "profit": 20297,
      "assets": 95221
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 30369,
      "profit": 8456,
      "assets": 21907
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 31838,
      "profit": 1916,
      "assets": 58425
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 117270,
      "profit": 17562,
      "assets": 91099
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 31232,
      "profit": 10310,
      "assets": 24353
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 30078,
      "profit": 2036,
      "assets": 58313
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 109822,
      "profit": 15655,
      "assets": 95572
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 33745,
      "profit": 14109,
      "assets": 28584
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 30012,
      "profit": 1764,
      "assets": 57199
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 128416,
      "profit": 21460,
      "assets": 110438
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 29871,
      "profit": 1751,
      "assets": 58582
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・医療・健康事業",
      "sales": 51363,
      "profit": 18215,
      "assets": 37747
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 135965,
      "profit": 22689,
      "assets": 118831
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 34138,
      "profit": 2628,
      "assets": 67656
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・医療・健康事業",
      "sales": 53998,
      "profit": 20558,
      "assets": 47125
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 133556,
      "profit": 21972,
      "assets": 127759
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 38775,
      "profit": 3130,
      "assets": 77144
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・医療・健康事業",
      "sales": 48033,
      "profit": 15697,
      "assets": 54911
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 150915,
      "profit": 29797,
      "assets": 133322
    }
  ]
}